University of Pittsburgh Medical Center,
Suite B400, UPMC Presbyterian, 200 Lothrop Street, Pittsburgh, Pennsylvania 15213
Tanzania
Research Article
Leukoencephalopathy after Whole Brain Radiation Therapy Plus Radiosurgery Versus Radiosurgery Alone for Metastatic Melanoma to the Brain
Author(s): Phillip A. Choi, Ajay Niranjan, Hideyuki Kano, L. Dade Lunsford and Edward A. Monaco IIIPhillip A. Choi, Ajay Niranjan, Hideyuki Kano, L. Dade Lunsford and Edward A. Monaco III
Advances in the treatment of melanoma with novel systemic therapies have meaningfully increased survival of patients. The brain is a common early site for melanoma metastases. WBRT is of limited effectiveness for radioresistant histologies such as melanoma and has been associated with white matter change and cognitive dysfunction. Prior studies of leukoencephalopathy after treatment with whole-brain radiation therapy (WBRT) and/or stereotactic radiosurgery (SRS) have focused on pathologies where chemotherapy is reflexively used in the majority of patients. The study’s aim was to evaluate the risk of leukoencephalopathy in patients with melanoma brain metastases receiving stereotactic radiosurgery and whole-brain radiation therapy versus SRS alone. We retrospectively reviewed 63 patients who underwent SRS with or without WBT between April 1988 and December 2012. Degree of leukoen.. Read More»
DOI:
10.4172/2155-9619.1000225
Nuclear Medicine & Radiation Therapy received 706 citations as per Google Scholar report